Evidence map›Paper›PMID 38281813›Full record

ReviewInternational journal of stem cells2024

Inducing Pluripotency in Somatic Cells: Historical Perspective and Recent Advances.

Junmyeong Park, Jueun Kim, Borami Shin, Hans R Sch Ler, Johnny Kim, Kee-Pyo Kim

Abstract readReview
PubMed Full text at PMC Publisher
In one paragraph

Review in International journal of stem cells, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Review
  6. Review
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Junmyeong ParkDepartment of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0009-0000-4679-3470
Jueun KimDepartment of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0009-0007-5254-2679
Borami ShinDepartment of General Pediatrics, University of Children's Hospital M?nster, M?nster, Germany.ORCID https://orcid.org/0009-0008-2206-6795
Hans R Sch LerDepartment of Cell and Developmental Biology, Max Planck Institute for Molecular Biomedicine, M?nster, Germany.ORCID https://orcid.org/0000-0002-7422-8847
Johnny KimDepartment of Cardiac Development and Remodeling, Max-Planck-Institute for Heart and Lung Research, Bad Nauheim, Germany.ORCID https://orcid.org/0000-0002-5226-5460
Kee-Pyo KimDepartment of Biomedicine & Health Sciences, College of Medicine, The Catholic University of Korea, Seoul, Korea.ORCID https://orcid.org/0000-0002-8666-8444

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Inducing pluripotency in somatic cells is mediated by the Yamanaka factors Oct4, Sox2, Klf4, and c-Myc. The resulting induced pluripotent stem cells (iPSCs) hold great promise for regenerative medicine by virtue of their ability to differentiate into different types of functional cells. Specifically, iPSCs derived directly from patients offer a powerful platform for creating

Indexed as

Cellular reprogrammingEmbryonic stem cellsInduced pluripotent stem cellsOctamer-binding transcription factor 4 (OCT4)Pluripotency

Identifiers

PMID38281813
PMCPMC11612216

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.